Cover Image

Modelling cost-effectiveness of tenofovir for prevention of mother to child transmission of hepatitis B virus (HBV) infection in South Africa

Abstract Background International sustainable development goals for the elimination of viral hepatitis as a public health problem by 2030 highlight the need to optimize strategies for prevention, diagnosis and treatment of hepatitis B virus (HBV) infection. An important priority for Africa is to hav...

Full description

Saved in:

Bibliographic Details
Main Authors:	Jolynne Mokaya (Author), Edward A. O. Burn (Author), Cynthia Raissa Tamandjou (Author), Dominique Goedhals (Author), Eleanor J. Barnes (Author), Monique Andersson (Author), Rafael Pinedo-Villanueva (Author), Philippa C. Matthews (Author)
Format:	Book
Published:	BMC, 2019-06-01T00:00:00Z.
Subjects:	article
Online Access:	Connect to this object online.
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

A systematic review of hepatitis B virus (HBV) drug and vaccine escape mutations in Africa: A call for urgent action.
by: Jolynne Mokaya, et al.
Published: (2018)

A Study of Knowledge, Experience, and Beliefs About Hepatitis B Virus (HBV) Infection in South Western Uganda
by: Joseph Mugisha, et al.
Published: (2019)

Renal safety of tenofovir and/or entecavir in patients with chronic HBV monoinfection
by: Yang YM, et al.
Published: (2017)

Development of a Transdermal Delivery System for Tenofovir Alafenamide, a Prodrug of Tenofovir with Potent Antiviral Activity Against HIV and HBV
by: Ashana Puri, et al.
Published: (2019)

Prevention strategies of mother‐to‐child transmission of hepatitis B virus (HBV) infection
by: Yao Hu, et al.
Published: (2020)

Exosomal lncRNA HOTTIP Mediates Antiviral Effect of Tenofovir Alafenamide (TAF) on HBV Infection
by: Liu QM, et al.
Published: (2021)

Tenofovir disoproxil fumarate for preventing mother-to-child transmission of hepatitis B: a literature review
by: Iulia Baciu, et al.
Published: (2021)

Distribution Evaluation of Tenofovir in the Breast Milk of Mothers With HBeAg-Positive Chronic HBV Infection After Treatment With Tenofovir Alafenamide and Tenofovir Disoproxil Fumarate by a Sensitive UPLC-MS/MS Method
by: Na Yang, et al.
Published: (2021)

Horizontal Modes of Transmission of Hepatitis B Virus (HBV): A Systematic Review and Meta-Analysis
by: SasidharanPillai Sabeena, et al.
Published: (2022)

Efficacy and safety of elvitegravir/cobicistat/emtricitabine/tenofovir alafenamide as maintenance treatment of patients with HIV and HBV co-infection
by: Y.-S. Huang, et al.
Published: (2019)

Tenofovir is superior to entecavir in reducing HCC for patients with HBV-related compensated cirrhosis at high HCC risk scores
by: Yan Huang, et al.
Published: (2022)

Improved pharmacokinetics of tenofovir ester prodrugs strengthened the inhibition of HBV replication and the rebalance of hepatocellular metabolism in preclinical models
by: Xiaodan Hong, et al.
Published: (2022)

Efficacy of Tenofovir Disoproxil Fumarate in Preventing Vertical Transmission of Hepatitis B in Mothers with Chronic Hepatitis B: An Evidence-Based Case Report
by: Ris Raihan Felim, et al.
Published: (2024)

A systematic review of Hepatitis B virus (HBV) prevalence and genotypes in Kenya: Data to inform clinical care and health policy.
by: Louise O Downs, et al.
Published: (2023)

A systematic review of Hepatitis B virus (HBV) prevalence and genotypes in Kenya: Data to inform clinical care and health policy
by: Louise O. Downs, et al.
Published: (2023)

Behavioral prevention of HBV transmission in urban communities toward global elimination of hepatitis in 2030: a systematic review
by: Fiya Diniarti, et al.
Published: (2024)

Tenofovir and its potential in the treatment of hepatitis B virus
by: Laura Reynaud, et al.
Published: (2009)

Non-Inferior Efficacy of Tenofovir Disoproxil to Tenofovir Disoproxil Fumarate in Virologically Suppressed Chronic Hepatitis B Patients
by: Yim HJ, et al.
Published: (2022)

Immunological Efficacy of Tenofovir Disproxil Fumarate-Containing Regimens in Patients With HIV-HBV Coinfection: A Systematic Review and Meta-Analysis
by: Taiyi Jiang, et al.
Published: (2019)

Successful treatment of HBV, HCV, & HEV, with 12-week long use of tenofovir, sofosbuvir, daclatasvir, and ribavirin: A case report
by: Braira Wahid
Published: (2020)

In situ analysis of hepatitis B virus (HBV) antigen and DNA in HBV-induced hepatocellular carcinoma
by: Ye Zheng, et al.
Published: (2022)

Barriers that prevent adults living with HBV infection from participating in clinical research: experience from South Africa
by: Nombuyiselo Mofokeng, et al.
Published: (2023)

Immunological response of Hepatitis B Virus Surface Antigen in HBV Mono and HBV/HDV Co-infection
by: Mehwish Sajjad, et al.
Published: (2024)

Cost-effectiveness of switching from tenofovir disoproxil fumarate to tenofovir alafenamide versus entecavir for chronic hepatitis B patients in Greece
by: Emmanouil Sinakos, et al.
Published: (2024)

Arresting vertical transmission of hepatitis B virus (AVERT-HBV) in pregnant women and their neonates in the Democratic Republic of the Congo: a feasibility study
by: Peyton Thompson, MD, et al.
Published: (2021)

Population pharmacokinetics of tenofovir given as either tenofovir disoproxil fumarate or tenofovir alafenamide in an African population
by: Aida N. Kawuma, et al.
Published: (2023)

Hepatitis B virus infection as a neglected tropical disease.
by: Geraldine A O'Hara, et al.
Published: (2017)

Tenofovir alafenamide in the treatment of chronic hepatitis B: design, development, and place in therapy
by: Ogawa E, et al.
Published: (2017)

Effectiveness and safety of tenofovir amibufenamide and its comparison with tenofovir alafenamide in patients with chronic hepatitis B: results from a retrospective real-world study
by: Lanqing Li, et al.
Published: (2023)

Tenofovir disoproxil fumarate in pregnancy for prevention of mother to child transmission of hepatitis B in a rural setting on the Thailand-Myanmar border: a cost-effectiveness analysis
by: Marieke Bierhoff, et al.
Published: (2021)

Tenofovir for prevention of mother to child transmission of hepatitis B in migrant women in a resource-limited setting on the Thailand-Myanmar border: a commentary on challenges of implementation
by: M. Bierhoff, et al.
Published: (2020)

THE COURSE OF CHRONIC HEPATITIS B IN INFANTS BORN TO MOTHERS WITH HBV-INFECTION
by: L. G. Goriacheva, et al.
Published: (2015)

Hepatitis B serologic patterns in children of HBV carriers or infected mothers
by: Julfina Bisanto, et al.
Published: (2016)

Viral hepatitis B and C in HIV-exposed South African infants
by: Cynthia Tamandjou Tchuem, et al.
Published: (2020)

Urine Assay to Measure Tenofovir Concentrations in Patients Taking Tenofovir Alafenamide
by: Linden Lalley-Chareczko, et al.
Published: (2020)

Evaluating the independent influence of sexual transmission on HBV infection in China: a modeling study
by: Miaolei Li, et al.
Published: (2021)

Comparison of the effectiveness and renal safety of tenofovir versus entecavir in patients with chronic hepatitis B
by: Beatriz López Centeno, et al.
Published: (2016)

Real-world impact of switching from tenofovir disoproxil fumarate to tenofovir alafenamide
by: Sarah M Michienzi, et al.
Published: (2021)

IDENTIFICATION OF X GENE MUTATIONS, GENOTYPE AND SUBGENOTYPE OF HEPATITIS B VIRUS (HBV)
by: Fatimawali, et al.
Published: (2014)

Media reporting of tenofovir trials in Cambodia and Cameroon
by: Wong Elaine, et al.
Published: (2005)